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Abstract 
Four new mixed-ligand Ni(II) complexes (1-4) containing imidazole (im) or benzimidazole (bz) 
and tridentate Schiff bases derived from 2,4-dihydroxybenzaldehyde (24D) and 4-methyl-3-
thiosemicarbazide (MT24D) or 4-phenyl-3-thiosemicarbazide (PT24D) were synthesised and 
characterised using elemental and spectral analysis including FTIR, UV-Vis, 1H NMR, 13C{1H} 
NMR and mass spectrometry for Schiff bases, while the complexes were additionally analysed 
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using ICP-OES, molar conductivity, magnetic susceptibility measurements and single crystal X-
Ray diffraction (SXRD) analysis. Magnetic susceptibility indicated a square planar geometry for 
all the metal complexes while molar conductance values showed that the complexes were non-
electrolytes in DMSO. The molecular geometries of the neutral complex molecule in 
[Ni(PT24D)(bz)](bz).CH3OH (2'), that is 2 co-crystallised with a 1,3-benzimidazole molecule as 
a methanol solvate, and in the cation of [Ni(MT24D)(im)]O2CMe.2H2O (5), a reaction 
intermediate for 1, were established by X-ray crystallography.  Each featured a trans-N2OS 
coordination geometry defined by phenoxide-O, imine-N and thiolate-S (2') or thione-S (5) 
donors as well as the imine-N donors derived from 1,3-benzimidazole (2') or imidazole (5) 
molecules.  Systematic variations in geometric parameters were correlated with the form of the 
tridentate ligand, i.e. di-anionic (2') or mono-anionic (5).  In the crystal of 2', supramolecular 
chains are sustained by hydrogen bonding and these were connected into a supramolecular layer 
by π…π stacking interactions occurring between coordinated benzimidazole rings.  In the crystal 
of 5, hydrogen bonding leads to a three-dimensional architecture.  By contrast, the Schiff bases 
and mixed-ligand Ni(II) complexes were tested for their cytotoxic activities, but all compounds 
were inactive against the tested breast cancer cell lines of MDA-MB-231 and MCF-7. 
Interestingly, the antibacterial analysis of the compounds showed that the PT24D Schiff base, 
Ni(MT24D)im, Ni(MT24D)bz, and Ni(PT24D)bz complexes had specific and selective activity 
against  Staphylococcus aureus (S. aureus), Bacillus subtilis (B. subtilis), Propionibacterium 
acne (P. acne) and Enterobacteraerogenes (E. aerogenes). The DNA binding studies of mixed-
ligand Ni(II) complexes against calf thymus DNA revealed that slight hypochromism was 
observed in the absorption spectra suggesting π-π interactions between the aromatic 
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chromophores and the DNA base pairs where 2 had higher Kb values than 1 indicating stronger 
interactions. 
1. Introduction 
In recent years, multi-drug resistance has become a serious issue resulting in failure of treatment 
due to resistance against currently available drugs. Therefore, the study of using transition metal 
complexes as metallo-drugs is believed to have great potential in wiping out the microbial 
menace by using different therapeutic approaches [1-2]. Small molecules like transition metal 
complexes have been proven to have strong binding interactions with DNA via both covalent and 
non-covalent interaction modes. The interaction modes play a significant role in the biological 
activities of metal complexes especially as antibacterial, antifungal and anticancer agents [3]. For 
example, the Cu(II) Schiff base complex derived from 4-chloroanthranilic and salicylaldehyde 
showed an intercalative binding mode with CT-DNA with a high Kb constant of 1.93 x 10
4 L 
mol-1, indicative of strong binding, as compared to other similar complexes such as [Cu(naph-
leu)phen]CH3OH·0.5H2O (Kb, 4.87 × 10
3 L mol−1) and [Cu(sal-L-val)phen] (Kb, 
6.48 × 103 L mol−1) [4]. This has formed the basis of most research in the synthesis of metal 
complexes via various methods and different designs to develop new metal-based drugs. 
Transition metal complexes of thiosemicarbazone ligands have received considerable 
interest due to its ability to disrupt DNA synthesis by causing modification in the reductive 
conversion of ribonucleotides to deoxyribonucleotides [5]. Furthermore, by introducing 
aldehydes or ketones to thiosemicarbazones, the Schiff bases that are formed can interact with 
metal ions to form complexes that have stable four, five or six coordination [6, 7]. The biological 
activity of thiosemicarbazones are affected by their chelating ability with transition metal ions. 
Coordination to metal centre through sulfur and nitrogen donors would form bidentate, tridentate 
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or even multidentate ligands, thus giving rise to complexes of different geometries and properties 
that would alter or enhancing their biological properties [8-11, 12]. Studies also reported that the 
biological activity of the metal complexes of thiosemicarbazone-derived Schiff bases often had 
higher, and selective bioactivities as compared to the corresponding free thiosemicarbazones [13-
15]. The biological activity of these metal complexes containing Schiff bases have also been 
reported to have enhanced activities when ligated to a co-ligand, forming mixed-ligand 
complexes. For instance, the Cu(II) complexes of a tridentate Schiff base, salicylaldehyde-4-
methyl-3-thiosemicarbazone in the presence of imidazole or benzimidazole indicated enhanced 
activity against MCF-7 and MDA-MD-231 breast cancer cell lines [16] as compared to the 
mono-ligand metal complex. 
Imidazole derivatives are an important class of heterocycles, being the core fragment of 
different natural products and biological systems. The imidazole ring is biologically relevant as it 
can mimic the histidine moiety. It is able to act as a co-ligand in metal complexes, potentially 
enabling them to bind with biomolecules [17].  They occupy a unique place in the field of 
medicinal chemistry owing to their potent biological activity especially as antiprotozoal, 
antifungal, and antihypertensive agents [18, 19-21]. Bearing donors and acceptors capable of 
hydrogen bonding, imidazole- and benzimidazole- containing metal complexes often possess 
interesting supramolecular architectures [22]. In the study of imidazole derivatives [23], 
Brandenburg reported that the compound synthesized from Cu(II) with salicylideneanthranilic 
acid and a co-ligand 2-methylimidazole [Cu(SAA)(MeImH)] had distinct superoxide dismutase 
activity (SOD) which yielded 50% inhibition of the reduction of NBT (IC50=35 µmol dm
-3) 
higher than native enzyme as the standard (IC50=0.004 µmol dm
-3). This higher IC50 value was 
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hypothesized to be due to the strong ligand field created by the tridentate Schiff base that would 
interfere with the interaction of the complexed copper ion with the superoxide radicals [24].  
In the present study, a new series of mixed-ligand metal complexes were formed by 
reacting single atom donor ligands, imidazole and benzimidazole with tridentate 
thiosemicarbazide Schiff bases and Ni(II) acetate. Since scarce information has been reported on 
mixed ligand metal complexes containing imidazole derivatives as a co-ligand and in view of the 
reports on the biological relevance of related mixed-ligand metal complexes, we report herein the 
synthesis, characterisation, cytotoxicity, antibacterial activity and DNA-binding studies of mixed 
ligand metal complexes derived from tridentate ONS Schiff bases with imidazole derivatives.  
 
2. Experimental 
2.1 Instrumentation and materials 
All chemicals were of analytical grade (A.R. from Alfa Aesar, Aldrich or Merck) 
and used without further purification. Elemental analysis (C, H, N) were performed 
using a LECO CHNS-932 elemental analyser. Infrared (IR) spectra were recorded on 
PerkinElmer 100 spectrophotometer (4000-280 cm-1). Molar conductance of 10-3 M 
solutions of the mixed-ligand Ni(II) complexes in DMSO were measured using a 
Jenway 4310 conductivity meter with a dip-type cell electrode. Magnetic susceptibility 
was measured with a Sherwood Scientific MSB-AUTO magnetic susceptibility balance 
at 298 K. UV-Vis spectra were recorded by using a Shimadzu UV-2501 PC recording 
spectrophotometer in the range of 1000-200 nm. Metal content of the complexes were 
determined using Inductive Coupled Plasma-Optical Emission Spectrometry. Nuclear 
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Magnetic Resonance (1H NMR and 13C NMR) spectra were recorded using an JNM 
ECA400 NMR spectrometer. 
 
2.2 Synthesis of 4-methyl-3-thiosemicarbazide-2,4-dihydroxybenzaldehyde (MT24D) and 4-
phenyl-3-thiosemicarbazide-2,4-dihydroxybenzaldehyde (PT24D). 
20 mmol (2.76 g) of 2,4-dihydroxybenzaldehyde was dissolved in 30 ml ethanol and 
added to an equimolar solution of 4-methyl-3-thiosemicarbazide (20mmol, 2.10 g) or 4-phenyl-
3-thiosemicarbazide (20 mmol, 3.34 g) in the same solvent. The mixture was stirred and reduced 
to half volume from initial volume. The precipitate that formed was recrystallised with cold 
ethanol. The yields were dried over silica gel overnight.  
For MT24D. Yield: (86%). Colour: light yellow, melting point: 215-216 ºC. Anal. Calc. 
For [C9H11N3O2S] C, 47.9; H, 4.9; N, 18.6. Found C, 47.2; H, 5.0; N, 18.6.data are given in 
Table 2 IR, ATR v(cm-1): 3240 v(O-H), 3336 v(N-H), 1616 v(C=N), 1013 v(N-N), 866 v(C=S). 
1H NMR (400 MHz, DMSO-d6, δ ppm): 11.41 (s, 1H, NH), 9.45 (q, 1H, J = 32 Hz, NH), 8.37 (s, 
1H, CH), 8.35 (s, 2H, OH phenolic), 7.33 (d, 1H, J = 4 Hz, Ar H), 6.74 (d, 1H, J = 8 Hz, Ar H), 
6.62 (t, 1H, J = 24 Hz, Ar H), 2.45 (d, 3H, J = 12 Hz, CH3). 
13C NMR (100 MHz, DMSO-d6, δ 
ppm): 177.12 (C8), 146.11 (C5), 144.67 (C3), 140.56 (C7), 121.45 (C6), 118.87 (C4), 116.98 
(C1), 116.85 (C2), 31.38 (C9). MS m/z 225 (M+1). 
For PT24D. Yield: (89%). Colour: yellow, melting point: 205-206 ºC. Anal. Calc. For 
[C14H13N3O2S] C, 58.5; H, 4.6; N, 14.6. Found C, 58.6; H, 4.9; N, 14.7.data are given in Table 2. 
IR, ATR v(cm-1): 3160 v(O-H), 3240 v(N-H), 1592 v(C=N), 1022 v(N-N), 825 v(C=S). 1H NMR 
(400 MHz, DMSO-d6, δ ppm): 11.71 (s, 1H, NH), 9.96 (s, 1H, OH phenolic), 9.55 (s, 1H, OH 
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phenolic), 8.94 (q, 1H, J = 32 Hz, NH), 8.43 (s, 1H, CH), 7.51 (d, 2H, J = 8 Hz, Ar H), 7.49 (d, 
1H, J = 12 Hz, Ar H), 7.33 (t, 2H, J = 16 Hz, Ar H), 7.14 (t, 1H, J = 16 Hz, Ar H), 6.78 (d, 1H, J 
= 16 Hz, Ar H), 6.64 (t, 1H, J = 12 Hz, Ar H). 13C NMR (100 MHz, DMSO-d6, δ ppm): 176.23 
(C8), 146.13 (C5), 145.39 (C3), 141.76 (C7), 139.68 (C9), 128 (C10, C14), 126.23 (C10, C11), 
125.57 (C1), 121.54 (C6), 119.40 (C4), 118.59 (C2), 117.20 (C12). MS m/z 287 (M+1). 
 
2.3 Synthesis of mixed-ligand Ni(II) complexes (1-4) 
2 mmol (0.43 g) Ni(CH3COO)2.H2O was dissolved in 20 ml of methanol. 8 mmol (0.54 
g) imidazole or benzimidazole (8 mmol, 0.95 g) in 30 ml dichloromethane was added to this 
solution. The mixture was stirred and heated for about 20 minutes. A solution of Schiff base, 
MT24D (2 mmol, 0.45 g) or PT24D (2 mmol, 0.57 g) was added to the metal-imidazole solution. 
The mixture was heated while stirring to reduce the volume to half. The precipitate formed when 
the mixture was cooled to room temperature, filtered and dried over silica gel overnight. For 
imidazole or benzimidazole to remain as a co-ligand, a large excess concentration was added in 
the reaction. A small amount of crystals suitable for single crystal X-ray structure analysis were 
obtained for 1 and 2 after slow evaporation in acetonitrile for a week.  
 
2.4 Single Crystal X-ray structure determination of [Ni(PT24D)(bz)](bz).CH3OH (2'), and in the 
cation of [Ni(MT24D)(im)]O2CMe.2H2O (5) 
In addition to crystals of 2', that is 2 co-crystallised with a 1,3-benzimidazole molecule as 
a methanol solvate, a small number of crystals of a reaction intermediate isolated from the 
reaction mixture of 1 were isolated and characterised crystallographically, hereafter 5.  Intensity 
data for 2' and 5 were measured at T = 100 K on an Oxford Diffraction Gemini Eos CCD 
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diffractometer fitted with Mo Kα radiation ( = 0.71073 Å).  Data reduction, including analytical 
absorption correction, was accomplished with CrysAlisPro [25].  The structures were solved by 
direct-methods [26] and refined (anisotropic displacement parameters, C-bound H atoms in the 
riding model approximation) on F2 [27].  The oxygen and nitrogen-bound hydrogen atoms were 
located from Fourier difference maps but refined with distance restraints O–H = 0.84±0.01 Å and 
N–H = 0.88±0.01 Å, respectively.  The only exception to this was for the O2w-water-bound 
hydrogen atoms in 5 which were included in their as-located positions constrained to O–H = 0.83 
Å.  Even restrained refinement of this water molecule proved unstable, an observation correlated 
with the relatively large displacement parameters associated with the O2w oxygen atom.  A 
consequence of this is that one of the hydrogen bonds formed by this water molecule is rather 
weak; it should be noted that the next closest potential acceptor atom for a hydrogen bond is 3.83 
Å distant.  A weighting scheme w = 1/[σ 2(Fo2) + (aP)2 + bP] where P = (Fo2 + 2Fc2)/3) was 
introduced in each case.  In the final cycles of the refinement of 5, a reflection, i.e. (-6 -4 8), was 
omitted owing to poor agreement.  The molecular structure diagrams was generated with ORTEP 
for Windows [28] with 70% displacement ellipsoids and the packing diagrams were drawn with 
DIAMOND [29].  Additional data analysis was made with PLATON [30].  Crystal data and 
refinement details are given in Table 1.  
 
Table 1 
Crystal data and refinement details for complexes 2 and 5. 
Complex 2 5 
Formula C16H15N5NiO2S, C7H6N2, CH4O C12H14N5NiO2S, C2H3O2.2H2O 
Formula weight 550.28 446.13 
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Crystal colour green brown 
Crystal system Triclinic Triclinic 
Space group P1¯ P1¯ 
a/Å 9.9399(6) 7.8339(7) 
b/Å 10.4759(7) 10.6523(8) 
c/Å 12.0659(7) 11.8297(7) 
/° 99.237(5) 98.363(5) 
/° 93.911(5) 101.635(6) 
/° 95.581(5) 100.212(7)  
V/Å3 1229.74(13) 934.61(13) 
Z 2 2 
Dc/g cm-3 1.486 1.585 
F(000) 572 464 
(MoK)/mm-1 0.915 1.192 
Measured data 10943 8119 
 range/° 2.4 – 25.2 2.4 – 25.2 
Unique data 5562 4206 
Observed data (I  2.0(I)) 4207 3531 
No. parameters 342 264 
R, obs. data; all data 0.045; 0.100 0.042; 0.099 
a; b in weighting scheme 0.051; 0.257 0.047; 0.550 
Rw, obs. data; all data 0.069; 0.112 0.053; 0.106 
GoF 1.05 1.04 
Range of residual electron 
density peaks/eÅ-3 -0.40 – 0.57 -0.48 – 0.96 
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2.5 Bioactivity 
2.5.1 Cytotoxicity assays 
MDA-MB-231 (estrogen receptor-negative human breast cancer cells) and MCF-7 
(estrogen receptor-positive human breast cancer cells) cell lines were obtained from the National 
Cancer Institute, USA. The cells were cultured in tissue culture flasks containing RPMI 1640 
culture medium supplemented with 1 % penicillin and 10 % fetal bovine serum (FBS). The 
cytotoxicity was determined by using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT) assay [31]. Cytotoxicity was expressed as IC50 which is the concentration of trial 
compound that inhibits the cancer cells by 50% as compared to the control. The control that 
contained untreated cells were included for each sample. Tamoxifen was used as a standard drug. 
2.5.2 Antibacterial activity 
Clinical isolates of the following organisms: Methicillin Resistant Staphylococcus aureus 
(MRSA), Staphylococcus aureus, Bacillus subtilis, Serratiamarcescens, Propionibacterium acne, 
Pseudomonas aeruginosa and Enterobacteraerogenes used in this study were obtained from the 
culture collection of the Institute of Bioscience, UPM. The bacterial strains were grown and 
maintained on nutrient agar (NA) slant. Antimicrobial activity was based on a clear zone formed 
around the disc. Complete inhibition was indicated by a clear zone, while partial inhibition was 
by a semi-clear zone. Streptomycin (100 mg/mL) was used as the reference drug for antibacterial 
activity with DMSO as the negative control. The bacterial suspension (108cfu/mL) was 
inoculated onto the entire surface of a nutrient agar (NA) plate with a sterile cotton-tipped swab 
to form an even lawn. After solidification, the filter paper discs impregnated with the extracts 
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were placed on the NA plates. The plates were then incubated at 37 °C for 18-24 hours. All tests 
were performed in triplicate and the antibacterial activity was expressed as the mean of the 
inhibition diameters (mm) obtained. 
 
2.5.2.1 Determination of minimum inhibitory concentration (MIC)  
The MIC values were determined by the liquid dilution method [32] for samples that 
displayed inhibition zones of around 15 mm and more in the disc diffusion assay. Various 
concentrations of each sample (ranging from 0.156-20 mg/mL) were prepared in 96-microwell 
plates followed by inoculating 10 µl of the standardized suspension bacteria. The microwell 
plates were incubated at 370C for 18-24 hours. The MICs of the samples were recorded as the 
lowest concentration that could inhibit the visible growth of microorganisms overnight. Each 
experiment was carried out three times and was correlated against the controls. 
 
2.5.2.2 Determination of minimum bactericidal concentrations (MBC)  
A loopful of sample from each well in the MIC examination which did not show any 
growth was inoculated on NA and incubated at 370C for 18-24 hours. In this test, the lowest 
concentration of sample required to kill a particular bacterium was determined as the MBC. 
 
2.5.3 DNA-binding study 
The buffer solution was prepared by adding 5 mM Tris-HCl (Sigma Aldrich) and 25 
mM NaCl (Sigma Aldrich) in 500 ml ultrapure water (pH = 7.1). The CT-DNA was 
dissolved in 25 ml of buffer solution [33]. The concentration of CT-DNA was calculated 
 12 
 
according to Beer-Lambert’s Law A = εbc, where ε is the molar extinction coefficient, 6600 
M-1 cm-1 at 260 nm [34]. The calculated DNA concentration was 5.136 x 10-5 M. The 
complexes were dissolved in a mixture of DMSO/buffer (3:7). Absorption titration 
measurements were carried out by gradually increasing the DNA concentration while 
maintaining the complex concentration (2 x 10-6 M). Absorbance values were recorded after 
each successive addition of DNA solution and equilibration using UV spectrophotometry 
[35].  
 
 
3. Results and discussion 
Schiff bases (MT24D and PT24D) were prepared by the condensation reaction of 2,4-
dihydroxybenzaldehyde with 4-methyl-3-thiosemicarbazide and 4-phenyl-3-thiosemicarbazide to 
form uninegatively-charged tridentate Schiff bases. The mixed-ligand Ni(II) complexes (1-4) 
were synthesized by reacting Ni(II) acetate, imidazole/benzimidazole (excess) and the Schiff 
bases in a one-pot reaction. The Schiff bases and mixed-ligand Ni(II) complexes were obtained 
in good yields with sharp melting points indicating that the compounds were relatively free of 
impurities. The Schiff bases were soluble in most common organic solvents while the mixed-
ligand Ni(II) complexes had limited solubility, and were only completely soluble in DMSO and 
THF. The physical properties and elemental analyses obtained for the Schiff bases and mixed-
ligand Ni(II) complexes are listed in Table 2. All physiochemical and spectroscopic analyses 
were carried out on the bulk samples. 
 
3.1 Magnetic and conductivity data 
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All the mixed-ligand Ni(II) complexes exhibited diamagnetic properties which was 
indicative of d8 Ni(II) complex with a square planar geometry [3] since the Schiff bases were 
expected to coordinate with the metal atom through three donor atoms while imidazole or 
benzimidazole occupied the fourth position. The complexes were non-electrolytes in DMSO 
[36], which fell in the range of 2.3-3.3 Ω-1 cm2 mol-1, indicating that both 
imidazole/benzimidazole and ligand did not exist as free ions in solution.  
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Table 2 
Physical properties and elemental analysis of the Schiff bases and mixed-ligand Ni(II) complexes. 
Compound (Mol. 
Wt.) 
Color M.P (ºC) Λa µb (B.M) 
(%) Found (Calcd.) 
C H N M 
MT24D (225.0) Light yellow 215-216 3.3 -  47.2 (47.9)  5.0 (4.9)  18.6 (18.6) - 
PT24D (287.3) Yellow 126-127 2.3 -  58.6 (58.5)  4.9 (4.6)  14.7 (14.6) - 
Ni(MT24D)im (1) 
(349.0) 
Brown > 300 2.5 Diamagnetic  41.9 (41.2)  4.1 (3.7)  20.7 (20.0)  16.2 (16.7) 
Ni(MT24D)bz (2) 
(399.0) 
Brown > 300 2.4 Diamagnetic  48.3 (48.0)  4.3 (3.8)  17.8 (17.5)  14.3 (14.6) 
Ni(PT24D)im (3) 
(411.0) 
Dark brown > 300 2.9 Diamagnetic  50.5 (49.9)  4.0 (3.6)  16.6 (16.9)  14.8 (14.2) 
Ni(PT24D)bz (4) 
(461.0) 
Brown > 300 3.5 Diamagnetic  54.2 (54.5)  3.9 (3.7)  15.4 (15.1)  12.9 (12.7) 
a Molar conductance (Ω-1 cm2 mol-1) of 10-3 M solutions in DMSO 
b Magnetic moments at 298 K 
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3.2 Electronic and IR spectra 
The infrared spectral data for the ligand and metal complexes are shown in Table 3 and 
Figs. S1, S2 and S3 (Supplementary file). Both ligands successfully coordinated to the metal ion 
through the phenoxide-oxygen, azomethine-nitrogen, and thiolate-sulphur atoms as evidenced by 
shift of wavenumbers of certain key functional groups in the IR spectra. The absence of the v(S-
H) band at 2570 cm-1 in the spectra of the ligands indicated that they existed as the thione form 
in the solid-state [35]. The thione forms are unstable and tend to convert to stable thiolo forms in 
the presence of metal ions, by enethiolization in solution [37]. In the infrared spectrum of 
MT24D and PT24D ligands, strong bands were observed at 1616 cm-1 and 1592 cm-1 
respectively, representing v(C=N) and these bands shifted to lower wavenumbers indicating that 
the metal ions coordinated through the azomethine-nitrogen. A weak v(C=N) band from 
imidazole or benzimidazole appeared in the region 1699-1748 cm-1 indicative of their presence 
as a co-ligand. A broad v(O-H) band was seen in the region of 3049 – 3240 cm-1 for both ligands 
and complexes. v(C=S) band appeared in the ligands at 866 cm-1 and 825 cm-1 for MT24D and 
PT24D respectively and shifted to lower wavenumbers upon complexation of the ligands and 
Ni(II) ion in the region of 732 -742 cm-1.  
The electronic spectral analysis was carried out in DMSO and the data is displayed in 
Table 4. The bands at 261-280 and 300-353 nm were attributed to intra-ligand n-π* and π-π* 
transitions respectively [38]. Weak d-d transitions displayed at 400-500 nm indicated that the 
complexes had square planar geometry where the Ni(II) ion was coordinated to the azomethine-
nitrogen, hydroxyl-oxygen, thiolate-sulphur from the Schiff base, whereas the fourth position 
was occupied by the co-ligand, imidazole or benzimidazole. The appearance of a strong peak at 
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347-377 nm additionally supported the ligation of sulphur to the metal ion via ligand to metal 
charge-transfer transitions.   
Table 3  
IR spectral bands of the Schiff bases and their mixed-ligand Ni (II) complexes 
Compound v (O-H) v (N-H) v (C=N)a,b v (N-N) v (C=S) v (C-S) 
MT24D 3240 3336 1616 1013 866 - 
PT24D 3160 3240 1592 1022 825 - 
1 3076 3383 1600, 1670 1071 - 732 
2 3095 3394 1594, 1748 1130 - 737 
3 3049 3362 1596, 1699 1022 - 742 
4 3162 3353 1593, 1700 1121 - 740 
a C=N from ligand 
b C=N from imidazole/benzimidazole  
Table 4 
Electronic absorption bands of the Schiff bases and their mixed-ligand Ni (II) complexes 
Compound  Electronic spectra (in DMSO)  λmax(log ε)c 
MT24D 280 (3.08) ; 348 (4.37) 
PT24D 279 (4.11) ; 353 (2.41) 
1 261 (4.80) ; 301 (3.92) ; 365 (4.13) ; 406 (3.99) 
2 279 (4.81) ; 300 (3.93) ; 369 (4.09) ; 404 (3.95) 
3 270 (6.43) ; 304 (6.48) ; 347 (6.54) ; 406 (7.61) 
4 280 (4.87) ; 308 (4.13) ; 377 (4.23) ; 411 (4.17) 
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3.3 1H NMR and 13C NMR spectra 
To obtain insight and confirm the structure of the tridentate Schiff bases, 1H NMR 
spectra of MT24D and PT24D (Figures S4 and S5, Supplementary Data) in DMSO-d6 were 
obtained. The summary of the spectral data is shown in Tables S1 and S2 (Supplementary Data). 
The 1H spectra MT24D showed a resonance in the downfield region around δ 11 ppm which was 
assigned as the proton (H7) which was attached to the N atom. The existence of the 
electronegative atoms (nitrogen) adjacent this proton deshields the proton. One singlet peak at δ 
8.35 and two singlets peaks at δ 9.55 and 9.96 ppm were observed correspond to OH phenolic of 
MT24D and PT24D, respectively. The aromatic protons were observed as multiplet ranging δ 
6.62 -7.33 ppm corresponding to 3 protons and δ 6.64 – 7.51 ppm corresponding to 8 protons for 
MT24D and PT24D, respectively. No resoance was observed at δ 4.0 ppm which indicated the 
absence of the thiol group which proved that the Schiff bases were present in their thione 
tautomeric form in solution [39]. This is quite common, as the thioamide functional group, -
NH(CS)NR- of the thiosemicarbazone Schiff bases is known to exhibit thione-thiol tautomerism 
in solution [39].  
The 13C{1H} NMR spectra and Distortionless Enhancement by Polarization Transfer 
(DEPT) experiments (Figures S6 and S7, Supplementary Data) were used to identify and assign 
the carbon atoms of the Schiff bases. The summary of the spectral data of MT24D and PT24D is 
shown in Table S2 (Supplementary Data). The signal due to the methyl group was observed at δ 
31.38 ppm. The thiocarbonyl group (–C=S) was assigned at the region δ 176.23 – 177.12 ppm in 
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the most deshielded regions. All the other aromatic carbon shifts were observed in the region of δ 
116.85 – 128.69 ppm [15].  
 
3.4 Crystal structures of [Ni(PT24D)(bz)](bz).CH3OH (2') and 
[Ni(MT24D)(im)]O2CMe.2H2O (5) 
Crystal structure determinations were achieved for 2' and 5 with the molecular 
structures of each of the complex molecules shown in Fig. 1.  The crystallographic 
asymmetric unit of 2' comprises a neutral complex molecule, a 1,3-benzimidazole molecule 
and a solvent methanol molecule.  The tridentate di-anion coordinates the nickel(II) centre 
via thiolate-S1, phenoxide-O3 and imine-N3 atoms to establish five- and six-membered 
rings.  The fourth site of the central atom is occupied by the N4 atom derived from a neutral 
benzimidazole molecule.  The nitrogen atoms are mutually trans within the resultant N2OS 
donor set that defines an approximate square-planar geometry.  Selected geometric data are 
given in Table 5 from which it can be seen that the maximum deviation from the ideal 
geometry, at least in terms of angles is found in the O1‒Ni‒N3 angle of 95.69(8)°. 
The crystallographic asymmetric unit of 5 comprises a complex cation, an acetate anion 
and two water molecules of crystallisation.  The tridentate mono-anion coordinates the nickel(II) 
centre via thione-S1, phenoxide-O3 and imine-N3 atoms.  The fourth site of the central atom is 
occupied by the N4 atom derived from a neutral imidazole molecule.  A very similar description 
of the coordination geometry pertains to the complex cation in 5 with the key difference being 
the thiolate-S1 donor in 2' is now a thione-S1 atom as the tridentate ligand is a mono-anion.  The 
major angular deviation from the square-planar N2OS coordination geometry is again seen in the 
O1‒Ni‒N3 angle of 94.90(8)°.  The experimental equivalence of the C13‒O3, O4 bond lengths, 
 19 
 
i.e. 1.244(4) and 1.249(3) Å, respectively, confirms the presence of the acetate counter-ion in the 
crystal of 5. 
Systematic changes in key geometric parameters are evident in Table 5, as a result of the 
different coordination modes of the LH- and L2- anions in 5 and 2', respectively.  Most notable is 
the longer Ni–S1 bond length in 5 compared with that in 2', with concomitant differences in the 
Ni–O1 bond lengths.  The short C1–S1 bond length in 5 is also consistent with the presence of a 
thione-S1 atom.  Also, the C1–N2 length of 1.308(3) Å in 2' is consistent with the formation of 
an imine bond in the L2- di-anion.  This change is also reflected in some of the key angles, e.g. a 
reduction of ca 6° in the C1‒N2‒N3 angle, and a decrease and increase by 5° and 4° in the 
S1‒C1‒N1 and S1‒C1‒N2 angles, respectively going from 5 to 2'. 
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Fig. 1.  Molecular structures of the complex molecules in (a) 2' and (b) 5, showing atom 
labelling schemes. 
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Table 5 
Selected geometric parameters (Å, °) for 2' and 5. 
Complex 2' 5 
Parameter 
Ni‒S1 2.1365(8) 2.1545(7) 
Ni‒O1 1.8799(18) 1.8597(17) 
Ni‒N3 1.862(2) 1.853(2) 
Ni‒N4 1.897(2) 1.894(2) 
N2‒N3 1.417(3) 1.397(3) 
C1‒S1 1.744(2) 1.715(2) 
C1‒N1 1.350(3) 1.326(3) 
C1‒N2 1.308(3) 1.453(3) 
C3‒N3 1.304(3) 1.301(3) 
S1‒Ni‒O1 174.82(6) 176.43(6) 
S1‒Ni‒N3 87.54(7) 88.60(6) 
S1‒Ni‒N4 89.95(7) 89.25(7) 
O1‒Ni‒N3 95.69(8) 94.90(8) 
O1‒Ni‒N4 86.94(8) 87.26(8) 
N3‒Ni‒N4 176.94(9) 177.47(9) 
C1‒N2‒N3 111.4(2) 117.4(2) 
N2‒N3‒C3 113.2(2) 115.2(2) 
S1‒C1‒N1 117.7(2) 122.78(19) 
S1‒C1‒N2 122.8(2) 118.61(19) 
N1‒C1‒N2 119.4(2) 118.6(2) 
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The tridentate mode of coordination of the L2- and LH- anions in 2' and 5 results in the 
formation of five-membered Ni,S1,C1,N2,N3 and six-membered Ni,O1,N3,C3-C5 chelate rings.  
While essentially planar, there are signficant deviations from planarity in the five-membered ring 
of 2': the r.m.s. deviation = 0.0210 Å with the N3 atom deviating by 0.0290(12) Å from this 
plane.  Even more pronounced are the deviations in the six-membered chelate ring with the r.m.s. 
deviation for the fitted atoms being 0.0459 Å, and with the N3 and Ni atoms lying 0.0723(14) 
and 0.0559(10) Å to either side of the plane, respectively; the dihedral angle between the chelate 
rings = 6.19(10)°.  Another description for the conformation of the six-membered chelate ring is 
one based on an envelope with the Ni atom being the flap atom, lying 0.152(3) Å out of the plane 
defined by the remaining five atoms [r.m.s. deviation = 0.0288 Å].  The coordinated 1,3-
benzimidazole molecule [r.m.s. deviation = 0.0125 Å] occupies a position almost perpendicular 
to the tridentate ligand as seen in the dihedral of 88.94(6)° formed between it and the five-
membered chelate ring.  The non-coordinating 1,3-benzimidazole molecule is also planar [r.m.s. 
deviation = 0.0125 Å].  A difference in conformation in the chelate rings is evident in 5.  In 5, 
both rings are planar with the greatest deviation from the five-membered ring [r.m.s. deviation = 
0.0091] being 0.0137(12) Å for the N3 atom.  The equivalent parameters for the larger chelate 
ring are 0.0108 Å and 0.0151(17) Å for the C5 atom.  The dihedral angle between the chelate 
rings is 0.861(9)°.  The imidazole ring is inclined with respect to the rest of the molecule as seen 
in the dihedral angle of 50.69(7)° it forms with the five-membered chelate ring. 
The other obvious difference in conformation between the complex molecules in 2' and 5 
relates to the relative orientations of the terminal amine-bound methyl groups.  While in both 
molecules, this group is co-planar with the coordinated S1 atom with S1–C1–N1–C2 torsion 
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angles of and 171.5(2) and -1.87(16)° in 2 and 5, respectively, in 5, the methyl group is syn to 
the S1 atom whereas there is an anti-relationship in 2'. 
The mode of coordination of the LH- anion in 5 appears to be unprecedented in the 
crystallographic literature according to a search of the Cambridge Structural Database [40].  
Similarly, with a formal C3-C4 bond in 2', this is also unprecedented with the closest structural 
analogue being a nickel(II) complex where this bond is substituted by a bond of an aromatic ring 
[41]. 
As anticipated from the chemical compositions of 2' and 5, significant hydrogen bonding 
interactions are evident in their crystals.  The geometric parameters characterising these along 
with other non-covalent interactions present in the respective crystals are tabulated in Table 6. 
 
Table 6 
Geometric parameters (Å, °) characterising intermolecular interactions in the crystals of 2' and 
5.a 
A H B H…B A…B A-H…B Symmetry operation 
2' 
O2 H2o N6 1.90(3) 2.741(3) 172(3) 1-x, 1-y, -z 
O3 H3o N2 1.982(13) 2.805(3) 164(4) 1-x, 1-y, 1-z 
N5 H5n O3 1.927(14) 2.804(3) 175(3) 1+x, y, z 
N7 H7n O1 1.96(3) 2.833(3) 169(3) -1+x, y, z 
N1 H1n Cg(1) 2.68(2) 3.480(2) 153.7(18) 1+x, y, 1+z 
5 
N1 H1n O3 1.937(18) 2.808(3) 173(3) 1-x, 1-y, 1-z 
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N2 H2n O4 1.842(17) 2.718(3) 176(3) 1-x, 1-y, 1-z 
O2 H2o O2w 1.99(2) 2.825(4) 172(3) x, y, z 
N5 H5n O1w 1.90(2) 2.759(3) 167(3) -x, 1-y, -z 
O1w H1w O1 2.01(3) 2.852(3) 177(3) x, y, z 
O1w H2w O4 1.93(3) 2.763(3) 171(3) x, y, z 
O2w H3w O3 1.96 2.678(5) 145 1-x, -y, -z 
O2w H4w O4 2.67 3.438(4) 154 x, y, z 
a Cg(1) is the ring centroid of the C18-C23 ring. 
 
Hydrogen bonding interactions also feature prominently in the molecular packing of 2'.  
The hydroxyl group of the complex molecule forms a hydroxyl-O–H…N(benzimidazole) 
hydrogen bond with a lattice benzimidazole molecule which, in turn, forms a benzimidazole-N–
H…O(methanol) hydrogen bond.  The solvent molecule functions in the same way by forming 
methanol-O–H…N(imine) and coordinated-benzimidazole-N–H…O(methanol) hydrogen bonds.  
The result is a supramolecular chain along the c-axis direction as shown in Fig. 2(a).  While there 
is no role formal role for the amine-N–H hydrogen in the hydrogen bonding scheme, this atom 
participates in the molecular packing by forming in a N–H…π(C6-benzimidazole) interaction 
within the supramolecular chain as detailed in Fig. 2(b).  The chains are connected into a 
supramolecular layer in the bc-plane by π…π stacking interactions between symmetry related 
benzimidazole rings, i.e. (N4,N5,C10-C12) and (C11-C16)i rings with an inter-centroid 
separation of 3.6142(16) Å and angle of inclination = 1.23(14)°; symmetry operation (i): 2-x, 2-
y, 1-z.  Layers stack along the a-axis direction without directional interactions between them, 
Fig. 2(c). 
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Fig. 2.  Supramolecular association in the crystal of 2: (a) a view of the supramolecular chain 
along the c-axis direction and sustained by O–H…N and N–H…O hydrogen bonding shown as 
orange and blue dashed lines, respectively, (b) detail of the amine-N–H…π interaction 
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highlighted as a purple dashed line and (c) a view in projection down the c-axis of the unit cell 
contents of 1 with π…π interactions shown as purple dashed lines. 
 
In the crystal of 5, the acetate anion spans the two amine-N–H atoms via two charge-
assisted amine-N–H…O(carboxylate) hydrogen bonds to form an eight-membered 
{…OCO…HNCNH} heterosynthon.  The presence of hydroxyl-O–H…O2w(water), imidazole-N–
H…O1w(water) and water-O1w…O2(phenoxide) hydrogen bond provide further links between 
the complex cation and the other constituents of the crystal.  Each of the carboxylate-O atoms 
forms a water-O-H…O(carboxylate) hydrogen bond, derived from different water molecules.  
Finally, the H4w atom participates in a long hydrogen bond with the carboxylate-O4 atom.  A 
view of the unit cell contents is shown in Fig. 3.  From here, globally, complex cations stack 
along the crystallographic a-axis and are connected into a three-dimensional architecture via the 
aforementioned hydrogen bonds which extend laterally from the columns. 
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Fig. 3.  A view in projection down the a-axis of the unit cell contents of 5.  The O–H…O and N–
H…O hydrogen bonds are shown as orange and blue dashed lines, respectively. 
 
5. Biological activities 
5.1 Cytotoxic activities 
The cytotoxicity studies of Schiff bases and mixed-ligand Ni(II) complexes were 
screened against two selected breast cancer cell lines, MCF-7 (human breast cancer with positive 
estrogen receptor) and MDA-MB-231 (human breast cancer with negative estrogen receptor). 
The IC50 values (concentration of drug that inhibits the growth of cancer cells by 50% as 
compared to the untreated controls) were determined. An IC50 value of less than 0.5 μM indicates 
that the complex is strongly active, whereas IC50 values of 0.5-5.0 μM and more than 5.0 μM 
indicate that the complex is moderately active and inactive, respectively [42]. The data obtained 
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showed all the compounds were inactive against the tested cancer cell lines. This could have 
been due to the presence of a hydroxyl group in the Schiff bases of Ni(II) complexes that 
reduced the cytotoxicity, probably due to the greater steric hindrance and intramolecular H-
bonding between the compounds [43]. Interestingly however, the PT24D and Ni(II) complexes 
were observed to have antibacterial potency against the bacterial strains tested.  
 
5.2 Antibacterial activities 
The Schiff bases, and mixed-ligand Ni(II) complexes were screened for their antibacterial 
properties against Staphylococcus aureus, Bacillus subtilis, Propionibacterium acne (Gram-
positive), and Pseudomonas aeruginosa, Serratiamarcescens, Enterobacteraerogenes (Gram-
negative). Streptomycin was used as a positive control and DMSO used as negative control in the 
antibacterial studies. The disc diffusion assay data is tabulated in Table 7 while the minimum 
inhibition concentration (MIC) and minimum bacterial concentration (MBC) results are recorded 
in Table 8. 
  The mixed-ligand Ni(II) complexes were observed to have better antibacterial activity 
compared to the Schiff bases suggesting that the metal ions reduced the polarity of the 
compounds through the partial sharing of positive charge with the donor atoms of Schiff bases 
[44]. Hence, π-electron delocalisation upon chelation which also increased the lipophilic 
character of the central metal atom allowed the Ni(II) complexes to have a stronger permeating 
ability to enter the permeable membrane of the bacterial strains [45]. This was also observed in 
similar mixed-ligand Ni(II) complexes with sap (salicylidene-2-aminophenol) and imidazole 
which had significant antibacterial activities compared to other  Ni(II) complexes containing 
only 2-carboxybenzaldehyde thiosemicarbazone [46,47]. The complexes in this study seemed to 
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be more bacteriocidal towards the gram-positive bacteria tested. Complex 2 had the smallest 
MIC and MBC values against Pseudomonas Aeruginosa whereas Complex 1 had small MIC and 
MBC values against a range of both positive and negative gram bacteria, suggesting that only 
small amounts of the metal complex were needed to inhibit/kill the growth of the micro-
organism [48].  
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Table 7 
Disc diffusion assay of the Schiff bases and mixed-ligand Ni(II) complexes against selected bacterial strains. 
Sample             
(20 mg/mL) 
Gram-positive bacteria Gram-negative bacteria 
Staphylococcus 
aureus 
Bacillus 
subtilis 
Propionibacterium 
acne 
MRSA 
Pseudomonas 
aeruginosa 
Serratiamarces
cens 
Enterobacteraer
ogenes 
MT24D 0 0 0 0 0 0 0 
1 19 ± 2 14 ± 1 17 ± 3 0 0 7 ± 1 0 
2 17 ± 2 13 ± 1 18 ± 1 0 0 0 0 
PT24D 12 ± 2 10 ± 1 14 ± 1 10 ± 1 0 9 ± 1 14 ± 1 
3 0 0 0 0 0 11 ± 1 0 
4 13 ± 2 11 ± 1 13 ± 1 0 0 0 10 ± 0 
Streptomycin  24 ± 2 29 ± 0 19 ± 0 28 ± 3 26 ± 1 21 ± 1 25 ± 1 
a Diameter of 15 mm and above is considered active; 0, inactive. 
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Table 8 
 Results of minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) (results are in mg/mL). 
Sample 
Staphylococcus 
aureus 
Bacillus 
subtilis 
Propionibacterium 
acne 
Enterobacteraerogenes 
MIC MBC MIC MBC MIC MBC MIC MBC 
1 0.63 1.25 10.0 20.0 0.63 1.25 - - 
2 1.25 2.50 - - 0.16 0.31 - - 
PT24D - - - - - - 10.0 20.0 
4 10.0 20.0 - - - - - - 
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5.3 DNA-binding studies  
Electronic absorption spectroscopy is a universal technique used to investigate the 
strength and mode of binding interactions between compounds 1 and 2 with CT-DNA [34]. The 
UV spectra of 1 and 2 in the absence and presence of CT-DNA is given in Figs. 4 and 5, 
respectively. Both spectra exhibited hypochromism of 17.2 % and 23.4 % for 1 and 2, 
respectively indicating that the π orbital of aromatic chromophore of the complexes interacted 
with π orbital of nucleobases of DNA [49]. The intrinsic binding constant Kb of the complex with 
CT-DNA was determined according to the following equation [4]: 
[DNA]/(εa−εf)=[DNA]/(εb−εf)+1/Kb(εb−εf), 
where [DNA] is the concentration of DNA in the base pairs, Kb is the intrinsic binding constant, 
εa corresponds to the apparent extinction coefficient, and εb and εf correspond to the extinction 
coefficients of the bound and free forms of the complex, respectively. The Kb value obtained for 
1 was 4.2 x 102 M-1 while for 2 it was 5.7 x 103 M-1 which was high, an indication of strong and 
stable interactions between the complexes and CT-DNA [50, 51]. Comparing the molecular 
structures of both the complexes, it was expected that the greater number of coplanar aromatic 
rings in the latter could have led to a higher affinity for DNA [52]. The interaction between 2 and 
DNA was also better than 1 possibly due to the presence of aromatic benzimidazole rings where 
the nitrogen atom of benzimidazole interacted well with the nucleobases of DNA. However, 
despite good Kb values, both complexes had weaker interactions as compared to the interaction 
of the standard, ethidium bromide with the DNA base pairs (Kb: 7 x 10
7 M-1) [53].  
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Fig. 4. Electronic spectra of 1 in Tris-HCl buffer upon addition of CT-DNA. The arrow shows 
the emission intensity changes upon increasing DNA concentration from 0 uL DNA to 240 uL 
DNA.  
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Fig. 5. Electronic spectra of 2 in Tris-HCl buffer upon addition of CT-DNA. The arrow shows 
the emission intensity changes upon increasing DNA concentration from 0 uL DNA to 240 uL 
DNA. 
 
6. Conclusions 
The reaction of Ni(II) acetate with Schiff bases derived from 4-substituted-3-
thiosemicarbazide and 2,4-dihydroxybenzaldehyde in the presence of imidazole or 
benzimidazole yielded a new series of mixed-ligand Ni(II) complexes, 1-4.  The Schiff bases 
coordinated to the Ni(II) ion via deprotonated ONS donor atoms and a monodentate nitrogen 
atom from imidazole or benzimidazole, yielding a distorted square planar geometry as was 
supported by spectroscopic analysis. Indirect evidence for the proposed structures were provided 
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by crystallographic methods. X-ray crystallography established the complex in 2' and complex 
cation in 5 and to exist within trans-N2OS square planar coordination geometry.  In 5, the sulphur 
atom is a thione as opposed to a thiolate in 2'.  The form (charge) of the tridentate ligand gave 
rise to systematic changes in bond lengths and angles.  Considerable hydrogen bonding led to a 
three-dimensional architecture in the crystal of 5 but, only one-dimensional chains in 2'.  All the 
tested compounds were inactive against the two selected breast cancer cell lines.  Although the 
complexes had higher activity than their free Schiff bases against the tested microbes, their Kb 
values were significantly lower than the standard, indicating that the complexes had a different 
mode of action against the tested cancer cells and microbes in this work. 
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Appendix A. Supplementary material 
Crystallographic data for 1 and 2 reported in this paper have been deposited with the Cambridge 
Crystallographic Data Centre (CCDC) as supplementary publication nos 1919663 (2') and 1919664 (5).  
These data can be obtained free of charge via www.ccdc.cam.ac.uk/getstructures.  Crystallographic 
diagrams and details of intermolecular interactions are given in Figures 1-3 and Tables 1, 5 and 6. 
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